HER2-Specific DARPin-Liposomes: Fabrication and Characterization

被引:1
|
作者
Guryev, E. L. [1 ]
Antonova, N. O. [1 ]
Yudintsev, A. V. [1 ]
Tretyakov, A. A. [1 ]
Stremovskiy, O. A. [2 ]
Shulga, A. A. [2 ]
Balalaeva, I. V. [1 ]
Deyev, S. M. [1 ,2 ]
Zvyagin, A. V. [1 ]
机构
[1] Lobachevsky State Univ Nizhny Novgorod, Prosp Gagarina 23, Nizhnii Novgorod 603950, Russia
[2] Russian Acad Sci, Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia
来源
BIOLOGICHESKIE MEMBRANY | 2016年 / 33卷 / 03期
关键词
PEGylated DARPin-liposomes; fluorescence; DARPin9-29; HER2; MACROMOLECULAR DRUGS; PHAGE DISPLAY; SOLID TUMORS; CELLS; PROTEINS; IMMUNOLIPOSOMES; NANOMEDICINES; THERAPEUTICS; ACCUMULATION; EXPRESSION;
D O I
10.7868/S023347551603004X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Liposomes based on natural lipids and their analogues are regarded as promising agents for targeted delivery of antitumor drugs. We have created and characterized in vitro DARPin-liposomes specifically interacting with HER2 cancer marker expressed on the surface of many types of cancer cells. The surface of the liposomes was coated with polyethylene glycol to increase the circulation time of the liposomes in the bloodstream and to reduce nonspecific uptake by macrophages. As a targeting agent we used high-affinity nonimmunoglobulin peptide DARPin9-29, specific to HER2 receptor. We anticipate that the created DARPin-liposomes can be used for targeted delivery of anticancer drugs with different mechanisms of action. Besides, the incorporation of fluorescent label rhodamine covalently bound to phospholipids offers the possibility of applying the DARPin-liposomes for diagnostic purposes. We suggest that DARPin-liposomes represent a perspective system for further development and creation of multifunctional liposomal formulations.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 50 条
  • [21] Preclinical models for the development of HER2-specific T-cell therapy
    Kreutzer, Christiane
    Conrad, Heinke
    Meyerhuber, Peter
    Uckert, Wolfgang
    Beckhove, Philipp
    Bernhard, Helga
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
    Hamilton, Erika
    Blackwell, Kimberly
    Hobeika, Amy C.
    Clay, Timothy M.
    Broadwater, Gloria
    Ren, Xiu-Rong
    Chen, Wei
    Castro, Henry
    Lehmann, Frederic
    Spector, Neil
    Wei, Junping
    Osada, Takuya
    Lyerly, H. Kim
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [23] Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
    Erika Hamilton
    Kimberly Blackwell
    Amy C Hobeika
    Timothy M Clay
    Gloria Broadwater
    Xiu-Rong Ren
    Wei Chen
    Henry Castro
    Frederic Lehmann
    Neil Spector
    Junping Wei
    Takuya Osada
    H Kim Lyerly
    Journal of Translational Medicine, 10
  • [24] ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA
    Burger, M. C.
    Zhang, C.
    Jennewein, L.
    Schoenfeld, K.
    Genssler, S.
    Grez, M.
    Tonn, T.
    Mittelbronn, M.
    Steinbach, J. P.
    Wels, W. S.
    NEURO-ONCOLOGY, 2014, 16
  • [25] ErbB2/HER2-specific natural killer cells for adoptive immunotherapy of glioblastoma
    Zhang, Concong
    Schoenfeld, Kurt
    Burger, Michael
    Genssier, Sabrina
    Sahm, Christiane
    Brendel, Christian
    Naundorf, Sonja
    Odendahl, Marcus
    Koehl, Ulrike
    Tonn, Torsten
    Grez, Manuel
    Steinbach, Joachim P.
    Wels, Winfried S.
    CANCER RESEARCH, 2013, 73 (08)
  • [26] Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
    Erika Hamilton
    Kimberly Blackwell
    Amy C Hobeika
    Timothy M Clay
    Gloria Broadwater
    Xiu-Rong Ren
    Wei Chen
    Henry Castro
    Frederic Lehmann
    Neil Spector
    Junping Wei
    Takuya Osada
    H Kim Lyerly
    Michael A Morse
    Journal of Translational Medicine, 11
  • [27] Antioxidant empowerment enhances antitumor functions of HER2-specific CAR T cells
    Balta, Emre
    Janzen, Nina
    Kirchgessner, Henning
    Orlik, Christian
    Liang, Jie
    Beate, Niesler
    Ruppert, Thomas
    Samstag, Yvonne
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 121 - 121
  • [28] Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
    Dreier, Birgit
    Mikheeva, Galina
    Belousova, Natalya
    Parizek, Petra
    Boczek, Edgar
    Jelesarov, Ilian
    Forrer, Patrik
    Plueckthun, Andreas
    Krasnykh, Victor
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 405 (02) : 410 - 426
  • [29] Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
    Honarvar, Hadis
    Calce, Enrica
    Doti, Nunzianna
    Langella, Emma
    Orlova, Anna
    Buijs, Jos
    D'Amato, Valentina
    Bianco, Roberto
    Saviano, Michele
    Tolmachev, Vladimir
    De Luca, Stefania
    SCIENTIFIC REPORTS, 2018, 8
  • [30] ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA
    Steinbach, Joachim P.
    Zhang, Congcong
    Burger, Michael
    Jennewein, Lukas
    Schoenfeld, Kurt
    Genssler, Sabrina
    Sahm, Christiane
    Brendel, Christian
    Naundorf, Sonja
    Odendahl, Marcus
    Koehl, Ulrike
    Nowakowska, Paulina
    Seifried, Erhard
    Boenig, Halvard
    Tonn, Torsten
    Grez, Manuel
    Mittelbronn, Michel
    Wels, Winfried S.
    NEURO-ONCOLOGY, 2014, 16